Title
Category
Credits
Event date
Cost
Gene Therapy for Sickle Cell Disease
  • Disease management
  • 0.25 ACPE - Pharmacists
  • 0.25 ACPE - Pharmacy Technicians
  • 0.25 AMA - Physicians
  • 0.25 ANCC - Nurses
  • 0.25 APA - Psychologists
  • 0.25 Attendance - General Attendance
$0.00
This patient‑led interview offers a compelling perspective on the real‑world impact of gene therapy for sickle cell disease, highlighting both dramatic physical improvements and the psychological and social adjustments that can follow transformative treatment. Through the patient’s lived experience, learners gain insight into how gene therapy may redefine identity, daily functioning, and long‑term expectations for health. The interview emphasizes the importance of patient‑centered communication, listening to patient expertise, and supporting ongoing mental and emotional adaptation as part of comprehensive, team‑based care.
Advancing COPD Care in Primary Practice: Early Diagnosis, Targeted Therapy, and High Value Interventions
  • Disease management
  • 1.00 AAPC - Coders
  • 1.00 ACPE - Pharmacists
  • 1.00 ACPE - Pharmacy Technicians
  • 1.00 AMA - Physicians
  • 1.00 ANCC - Nurses
  • 1.00 Attendance - General Attendance
03/31/2026
$0.00
This live webcast will provide primary care clinicians with a practical, guideline aligned approach to improving COPD care, including earlier and more accurate diagnosis through consistent spirometry use and optimization of inhaled therapy. It will highlight targeted and appropriate use of inhaled corticosteroids (ICS), including how to identify patients unlikely to benefit and how to minimize ICS-related risks. The activity will also review standardized strategies for managing exacerbations, emphasize high value non pharmacologic interventions—particularly pulmonary rehabilitation, inhaler technique education, and adherence support—and outline coordinated, cost-conscious care pathways, including appropriate pulmonology referral and careful selection of advanced therapies such as biologics for those patients most likely to benefit.

Pages